MedTrace Logo

Brain Stimulation and Aphasia Treatment

NCT01686373 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 74

Last updated 2019-08-20

Study results available
· View outcomes & findings →

Summary

The purpose of this study is to assess the changes in language processing of patients with chronic, post-stroke aphasia following the application of brain stimulation. The brain stimulation the investigators administer is called transcranial direct current stimulation (tDCS). It involves passing a weak electrical current through the brain between two electrodes in the form of damp sponges. One sponge will be placed over a specified area on the damaged left hemisphere, while the other sponge will be placed on the right scalp. Computer-controlled speech-language treatment will be administered during the application of tDCS.

Conditions

  • Aphasia

Interventions

DEVICE

Activa Dose II Real tDCS

20 minutes of 1 milliamp active tDCS per treatment day (15 total sessions)

DEVICE

Activa Dose II Sham tDCS

20 minutes of sham stimulation per treatment day (15 total sessions)

Sponsors & Collaborators

  • National Institute on Deafness and Other Communication Disorders (NIDCD)

    collaborator NIH

  • Medical University of South Carolina

    collaborator OTHER

  • University of South Carolina

    lead OTHER

Principal Investigators

  • Julius Fridriksson, PhD · Director

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
25 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-04-30
Primary Completion
2017-05-31
Completion
2017-10-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01686373 on ClinicalTrials.gov